JP2005536507A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005536507A5 JP2005536507A5 JP2004521592A JP2004521592A JP2005536507A5 JP 2005536507 A5 JP2005536507 A5 JP 2005536507A5 JP 2004521592 A JP2004521592 A JP 2004521592A JP 2004521592 A JP2004521592 A JP 2004521592A JP 2005536507 A5 JP2005536507 A5 JP 2005536507A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyrrolo
- compound
- pyridazine
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39473402P | 2002-07-11 | 2002-07-11 | |
| PCT/US2003/021493 WO2004006836A2 (en) | 2002-07-11 | 2003-07-08 | Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005536507A JP2005536507A (ja) | 2005-12-02 |
| JP2005536507A5 true JP2005536507A5 (https=) | 2006-04-20 |
Family
ID=30115760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004521592A Pending JP2005536507A (ja) | 2002-07-11 | 2003-07-08 | ６Ｈ−ピロロ［３，４−ｄ］ピリダジン化合物による神経障害性疼痛の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7465730B2 (https=) |
| EP (1) | EP1539168A2 (https=) |
| JP (1) | JP2005536507A (https=) |
| AU (1) | AU2003248907B2 (https=) |
| CA (1) | CA2492022A1 (https=) |
| WO (1) | WO2004006836A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR047759A1 (es) | 2003-09-26 | 2006-02-22 | Vertex Pharma | Derivados de fenil - piperazina como moduladores de receptores muscarnicos |
| GB0405200D0 (en) * | 2004-03-08 | 2004-04-21 | Pfizer Ltd | Combinations comprising alpha-2-delta ligands |
| JP2009510090A (ja) | 2005-09-27 | 2009-03-12 | ミリアド ジェネティックス インコーポレーティッド | 治療化合物としてのピロール誘導体 |
| CN101003537A (zh) * | 2006-01-17 | 2007-07-25 | 上海恒瑞医药有限公司 | 吡咯并哒嗪类衍生物及其制备方法和用途 |
| TW200914457A (en) * | 2007-05-31 | 2009-04-01 | Kyowa Hakko Kogyo Kk | Pyrimidodiazepinone derivative |
| EP2657219B1 (en) | 2007-09-28 | 2014-12-10 | Daiichi Sankyo Company, Limited | Intermediate for producing bicyclic y-amino acid derivative |
| DK3106166T3 (da) | 2008-02-29 | 2021-01-11 | Vm Therapeutics Llc | Forbindelser til behandling af smertesyndrom og andre lidelser |
| WO2010002877A2 (en) * | 2008-07-03 | 2010-01-07 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| GB0813144D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
| JP5557292B2 (ja) | 2009-03-26 | 2014-07-23 | 第一三共株式会社 | 二環性γ−アミノ酸誘導体の製造方法 |
| WO2012169475A1 (ja) | 2011-06-08 | 2012-12-13 | 第一三共株式会社 | クライゼン転位反応による二環性化合物の製造方法 |
| EP2719676B1 (en) | 2011-06-08 | 2017-12-13 | Daiichi Sankyo Company, Limited | Method for producing bicyclic compound via iminium salt |
| IN2014MN01046A (https=) | 2011-12-15 | 2015-05-01 | Daiichi Sankyo Companyltd | |
| EP2837689B1 (en) | 2012-04-10 | 2017-02-15 | Daiichi Sankyo Company, Limited | Optical resolution method for bicyclic compound using enzyme |
| WO2014069626A1 (ja) * | 2012-11-01 | 2014-05-08 | 協和発酵キリン株式会社 | ピリミドジアゼピノン化合物の製造方法 |
| EP2928891B1 (en) | 2012-12-04 | 2019-02-20 | Rigel Pharmaceuticals, Inc. | Protein kinase c inhibitors and uses thereof |
| TWI635071B (zh) | 2013-07-08 | 2018-09-11 | 第一三共股份有限公司 | 光學活性二環γ－胺基酸衍生物及其製造方法 |
| WO2018100041A1 (en) * | 2016-11-30 | 2018-06-07 | Laboratorios Del Dr. Esteve, S.A. | Meta substituted phenylpyrazolo- and phenylpyrrolo- pyridazine derivatives having multimodal activity against pain |
| WO2018100045A1 (en) * | 2016-11-30 | 2018-06-07 | Laboratorios Del Dr. Esteve, S.A. | Ortho substituted phenylpyrazolo- and phenylpyrrolo-pyridazine derivatives having multimodal activity against pain |
| EP3630765A1 (en) * | 2017-05-30 | 2020-04-08 | Esteve Pharmaceuticals, S.A. | Substituted pyrrolidinyl and piperidinyl pyrazolopyridazine derivatives having multimodal activity against pain |
| GB202106872D0 (en) * | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622948A (en) * | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
| GB9726701D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
-
2003
- 2003-07-08 US US10/520,962 patent/US7465730B2/en not_active Expired - Fee Related
- 2003-07-08 EP EP03764414A patent/EP1539168A2/en not_active Withdrawn
- 2003-07-08 CA CA002492022A patent/CA2492022A1/en not_active Abandoned
- 2003-07-08 AU AU2003248907A patent/AU2003248907B2/en not_active Ceased
- 2003-07-08 JP JP2004521592A patent/JP2005536507A/ja active Pending
- 2003-07-08 WO PCT/US2003/021493 patent/WO2004006836A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005536507A5 (https=) | ||
| US12331052B2 (en) | Organic compounds | |
| AU2018307479B2 (en) | Organic compounds | |
| AU2018307480A1 (en) | Organic compounds | |
| JP2007509150A5 (https=) | ||
| AU2020254812B2 (en) | Methods of treating neuropathic pain | |
| JP2006522128A5 (https=) | ||
| CN120417904A (zh) | 作用于血清素5-HT2A受体的杂环稠合γ-咔啉 | |
| KR102491214B1 (ko) | 중수소화 덱스트로메토르판의 합성 방법 | |
| JP5134755B2 (ja) | ４−（オキサゾロピリジン−２−イル）−１，４−ジアザビシクロ−［３．２．２］ノナン誘導体、それらの製造と治療的使用 | |
| SK15652003A3 (sk) | Kombinácia účinných látok na medikamentóznu terapiu návykových alebo omamných prostriedkov | |
| JP2575569B2 (ja) | 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法 | |
| JP3123080B2 (ja) | 「インドール誘導体およびその医薬用途」 | |
| JP2008094795A (ja) | 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤 | |
| JP4292738B2 (ja) | インドール誘導体およびその医薬用途 | |
| US5714483A (en) | Antitussive | |
| JPWO1997011948A1 (ja) | インドール誘導体およびその医薬用途 | |
| Cai et al. | Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3 R)-7-hydroxy-N-((1 S)-1-{[(3 R, 4 R)-4-(3-hydroxyphenyl)-3, 4-dimethyl-1-piperidinyl] methyl}-2-methylpropyl)-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide (JDTic) | |
| Zlotos et al. | Muscarinic receptor agonists and antagonists | |
| MX2010009110A (es) | Beloxepina, sus enantiomeros, y analogos de la misma para el tratamiento de dolor. | |
| JPS5855489A (ja) | アルフア２拮抗剤組成物 | |
| Owen et al. | Almorexant | |
| TW200305413A (en) | Derivatives of 5- (pyridin-3-yl)-1-azabicyclo [3. 2. 1] octane, their preparation and their therapeutic application | |
| SK212000A3 (en) | 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy | |
| JP2005536522A5 (https=) |